Pasqal Holding SA acquires Bleichroeder Acquisition Corp. II
Acquisition Provisional 90% confidence first seen
Pasqal Holding SA completed a merger with the SPAC Bleichroeder Acquisition Corp. II, after which Pasqal began trading on Nasdaq under the ticker PSQL (with warrants PSQLW). The coverage says the deal closed with Pasqal reporting roughly $360 million in cash available and that the transaction valued Pasqal at about $2 billion in the prior funding round (with a pro forma market cap cited around $2.6 billion). This matters because it provides capital and public-market access to scale manufacturing, expand quantum processing units (QPUs), and invest in fault-tolerant development and related cloud/HPC software efforts.
The deal
Bleichroeder Acquisition Corp. II Undisclosed Acquisition · announced 28 Aug 2026
Investors Pasqal Holding SA
Deal terms as reported in the coverage below.
Decision brief
- What changed
- Pasqal Holding SA completed its merger with Bleichroeder Acquisition Corp. II and began trading on Nasdaq under the ticker PSQL, with warrants trading as PSQLW. According to the coverage, Pasqal said it closed the transaction with about $360 million in cash to fund its next phase of growth.
- Why it matters
- This gives Pasqal both capital and public-market access to fund manufacturing expansion, QPU rollout, and investment in fault-tolerant development and cloud/HPC software integration. For business leaders evaluating quantum partnerships, suppliers, or competitive positioning, the listing signals that Pasqal may have greater capacity to scale product delivery and commercial operations. The event also raises the company’s visibility with enterprise and government buyers, which could affect procurement and ecosystem decisions, although the coverage does not confirm specific customer impacts.
- Evidence
- The provided coverage comes from a single report by Trending Topics EU, which states that Pasqal completed the merger, started trading on Nasdaq, and reported roughly $360 million in cash after closing. The same report says the proceeds are intended for manufacturing expansion, QPU deployment, fault-tolerant development, cloud/software, HPC integration, and sales scaling.
- What remains uncertain
- The coverage is based on one article and does not independently verify the reported cash balance, valuation references, or how much of the capital is unrestricted and available for operations. It also does not show the timeline for manufacturing scale-up, commercial traction, or whether public-market access will translate into durable execution advantages.
- Monitor next
- Watch Pasqal’s first public-company filings and earnings disclosures for cash deployment, manufacturing milestones, QPU rollout progress, and any announced enterprise or government contracts.
Analytical support, not advice — assumptions and open questions stated above.